Kyowa Kirin Co Ltd 2025 Integrated Report
The report describes Kyowa Kirin's FY2025 performance as a global specialty pharmaceutical group, with record revenue of ¥496.8 billion and 5,161 consolidated employees. It highlights the continued global expansion of products such as Crysvita and Poteligeo, the launch of KOMZIFTI in the United States, and the integration of Orchard Therapeutics' gene-therapy capabilities. Environmental progress includes reported 2025 Scope 1 and Scope 2 emissions of 15,407 and 362 t-CO2, respectively, alongside an approximately 70% reduction in annual CO2 emissions from the 2019 baseline. The report also sets targets for 55% Scope 1+2 and 30% Scope 3 reductions by 2030, with net-zero value-chain emissions by 2050.
Company: Kyowa Kirin Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Integrated Report
Pages: 58
Kyowa Kirin Co Ltd
The report describes Kyowa Kirin's FY2025 performance as a global specialty pharmaceutical group, with record revenue of ¥496.8 billion and 5,161 consolidated employees. It highlights the continued global expansion of products such as Crysvita and Poteligeo, the launch of KOMZIFTI in the United States, and the integration of Orchard Therapeutics' gene-therapy capabilities. Environmental progress includes reported 2025 Scope 1 and Scope 2 emissions of 15,407 and 362 t-CO2, respectively, alongside an approximately 70% reduction in annual CO2 emissions from the 2019 baseline. The report also sets targets for 55% Scope 1+2 and 30% Scope 3 reductions by 2030, with net-zero value-chain emissions by 2050.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 2025 - Dec 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Women in Management
Net Zero Target
Employees